What changed in the ASML orbit

Brainport suppliers live inside an asymmetric market. For a given subsystem there are often only two to four credible Dutch integrators, and one buyer's roadmap can absorb most of the engineering bench. That works fine until the buyer's visibility collapses or the addressable market gets repriced by policy.

Both happened. ASML's China revenue moved from roughly 49% to 20%. Q1 2024 bookings landed at EUR 3.6 billion versus EUR 9.2 billion in Q4 2023. Suppliers with China-destined volume and more than 60% ASML concentration were exposed to two problems at once: demand uncertainty and a diversification gap they could not close in time.

ASML-Linked Supplier Signals
49→20%
ASML China Revenue
9.2→3.6B
Quarterly Bookings
>60%
Existential Concentration
>15%
Revenue at Export Risk

Why the old playbook fails

The usual response is commercial theater. Update the website. Go to another trade show. Tell sales to open more accounts. None of this changes anything if the engineering bench is still monopolized by the anchor customer and the firm cannot quote a second roadmap with confidence.

The bottleneck is not lead generation. It is diversification capacity. A supplier above 50% ASML concentration with long-open mechatronics roles and an unquotable backlog does not have a top-of-funnel problem. It has a sequencing problem. Which adjacent accounts can it actually serve, in which geography, with which delivery promise, at which moment in the cycle.

The real threshold

Below 25% from one OEM, GTM can be opportunistic. Between 25% and 50%, it has to be disciplined. Above 50%, GTM becomes a diversification program. Above 60%, it becomes a survival program.

What the new playbook looks like

Start with adjacency, not volume. The credible path is usually not "win ten new logos." It is "reduce the dependency ratio by landing one or two adjacent programs where the capability overlap is high enough that quoting risk stays acceptable." In Brainport that often means moving laterally across semicon-adjacent, photonics, precision systems (different pain phases across the three clusters), defense-linked work.

Second is geography. Malaysia, Vietnam, Singapore. These are not lifestyle expansion stories. In this market they are decoupling signals. When a supplier joins a Brainport Industries Asia mission, posts a trade-compliance role, or sets up MIDA registration, it is telling you that export exposure is already affecting strategy.

Third is commercial packaging. Suppliers tied to one roadmap tend to talk in capability lists. Too soft. The stronger message is risk absorption: shorter NPI cycles, quoting confidence, alternate geography readiness, compliance maturity, proof that the firm can carry a second roadmap without breaking the first one.

Operator note

The winning posture is not "we also serve other sectors." Everybody says that. The useful commercial claim is narrower: we can take on this adjacent scope without creating a delivery gamble. That is what buyers actually need from a supplier leaving captivity.

Signals to watch

What this means commercially

If you sell to this market, generic "help you grow" language is a waste of everyone's time. The better conversation depends on which signal is live. Export exposure opens a different door than unquotable backlog. Capacity-planning, MES, ERP modernization, engineer productivity, Asia-footprint advisory, compliance support. All fit here. But not at the same time and not with the same opening.

The useful GTM model is signal-gated — why signal-based targeting outperforms. Watch concentration, export shifts, hiring persistence, quoting behavior. Time the outreach when the supplier has already felt the pain but has not yet stabilized around a new operating model.

Next step

Map ASML concentration to real buying windows

Paioneers builds GTM systems that turn export, hiring, and concentration signals into account-priority logic.

Book a Workshop